Suchergebnisse - "Yu, Mingjun"

PubPharm (39)

1

Compound with syringic acid and amino acid structural fragments and synthesis and application thereof

enthalten in: Europäisches Patentamt | 2023

von YAO RISHENG | YU MINGJUN | LIU QINGCHUAN | +2

2

HDAC6 inhibitor containing chalcone structure as well as preparation method and application of HDAC6 inhibitor

enthalten in: Europäisches Patentamt | 2023

von YAO RISHENG | YU MINGJUN | WANG HUAI | +2

3

Simvastatin represses inflammation and cell apoptosis in COPD rats via rho/rho kinase signaling pathway

enthalten in: Minerva surgery | 2023

von Zhao, N. | Yu, M. | Lan, B. | +4

4

Retraction Note to : Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

enthalten in: Molecular cancer | 2022

von Yu, M. | Xue, Y. | Zheng, J. | +5

RetractionOf: Mol Cancer. 2017 Jun 26;16(1):110. - PMID 28651608

5

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway

enthalten in: Molecular cancer | 2022

von Yu, M. | Xue, Y. | Zheng, J. | +5

6

Preparation method of high-osteoinductivity alpha-tricalcium phosphate nano-powder for 3D printing

enthalten in: Europäisches Patentamt | 2022

von NIE JIANHUA | WANG JUN | HOU YONG | +4

7

Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin

enthalten in: Anti-cancer agents in medicinal chemistry | 2022

von He, M. | Yu, M. | Li, C. | +4

8

LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis

enthalten in: Journal of cellular and molecular medicine | 2022

von Yi, B. | Li, H. | Cai, H. | +3

9

LncRNA KCNQ1OT1 predicts further cerebral events in patients with transient ischemic attack

enthalten in: Frontiers in pharmacology | 2022

von Yu, S. | An, J. | Sun, R. | +2

10

Design, Synthesis and Biological Evaluation of Novel 1, 3, 4-Oxadiazole PD176252 Analogues as Potential GRPR Inhibitors

enthalten in: Anti-cancer agents in medicinal chemistry | 2022

von Zhu, Y. | Wang, H. | Yu, M. | +4